## FTV: Fortive Corporation - XLK: Technology

### Executive Summary

No thesis match: MRS_10 1.2% below STRENGTH zone (3.0-6.0%); PEG 1.29 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-1.8% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($52.64)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 1, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-08 | Citigroup | $59 | $57 | +4% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-08 | Citigroup | main | Neutral |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 6 ($0.00M) |
| Sells | 2 ($3.09M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 62.8% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 5 / 5 |

**Top Holders:**
- Dodge & Cox Inc.: 13.4% (+28.4%)
- Vanguard Group Inc: 12.3% (-0.8%)
- Blackrock Inc.: 9.8% (-0.5%)
- Viking Global Invest: 6.5% (+28.7%)
- Price (T.Rowe) Assoc: 4.9% (+8.3%)

### Key Risks

1. Insider selling cluster: $3.1M in recent transactions.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 1.29 suggests fair value with growth premium. Forward P/E 19.2x stretched relative to 8% growth. Insider selling cluster ($3.1M in 90 days), potential headwind. Institutional flow bullish (5 buying vs 5 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $18.5B |
| Beta | 1.04 |
| 52W Range | $45.50 - $62.79 |
| Short Interest | 5.5% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.29 |
| Forward P/E | 19.2 |
| Current P/E | 20.7 |
| YoY Growth | 7.8% |
| EPS Direction | STABLE |

### Technicals

MRS_10 deteriorating from 3.1% to 1.2% (-1.8% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 1.8pp (needs >3.0% for momentum thesis). MRS_5 (-0.5%) diverging from MRS_10 - short-term weakness emerging. Full SMA alignment bullish (above 20/50/200 SMAs). RSI neutral at 60. OFD pattern: -MTN (Decline).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 1.25% (CS: 54) | Neutral |
| RSI_14 | 60.0 | Neutral |
| MACD Histogram | 0.01 | Bullish |
| vs SMA20 | 1.017x | Above |
| vs SMA50 | 1.061x | Above |
| vs SMA200 | 1.062x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $54.66
- **Stop Loss:** $52.64 (3.7% risk)
- **Target:** $56.68 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 470
- **Position Value:** $25,690.20
- **Portfolio %:** 25.69%
- **Risk Dollars:** $950.00
- **Risk Per Trade:** 0.95%
- **Modifiers:** L1 95% | L2 100% | Combined 0.95x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 0.95x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with cautious positioning ahead of CPI data. VIX at moderate 16.87 with positive yield curve suggesting stable growth, but narrow breadth at 51.8% indicates selective participation. Banking sector optimism and corporate resilience provide support, though AI volatility creates pockets of uncertainty.*

### Earnings

**Next:** 2026-02-04 (Est: $0.84)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.57 | $0.68 | +19.5% |
| 2025Q2 | $0.59 | $0.58 | -2.1% |
| 2025Q1 | $0.85 | $0.85 | -0.2% |
| 2024Q4 | $1.12 | $1.17 | +4.4% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*